Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Enteromedics Inc (ETRM) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 37,500
  • Shares Outstanding, K 390
  • Annual Sales, $ 290 K
  • Annual Income, $ -25,500 K
  • 36-Month Beta 2.10
  • Price/Sales 46.88
  • Price/Book 4.65

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.75 +221.14%
on 01/04/17
30.41 -81.52%
on 01/10/17
+1.42 (+33.81%)
since 12/16/16
3-Month
1.75 +221.14%
on 01/04/17
30.41 -81.52%
on 01/10/17
-1.38 (-19.71%)
since 10/18/16
52-Week
1.75 +221.14%
on 01/04/17
132.30 -95.75%
on 02/04/16
-90.98 (-94.18%)
since 01/15/16

Most Recent Stories

More News
EnteroMedics Announces Pricing of $16.5 Million Underwritten Public Offering

EnteroMedics Inc. (NASDAQ:ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced the pricing of...

Stock Market Roundup, Jan. 10: NVDA Self-Driving Cars, ETRM Soars

Stocks continued their relatively solid start to the New Year with another positive day of trading on Tuesday. Perhaps the biggest newsmakers on the day were NVIDIA and Mercedes-Benz, as the pair announced...

EnteroMedics Announces Retirement of All Senior Convertible Notes

EnteroMedics Inc. (NASDAQ:ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that as of Tuesday,...

Blog Coverage EnteroMedics Announced 1-for-70 Reverse Stock Split and Amortization of its Convertible Notes

Upcoming AWS Coverage on ViewRay, Inc. Post-Earnings Results

EnteroMedics Announces 1-for-70 Reverse Stock Split

EnteroMedics Inc. (NASDAQ:ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the EnteroMedics...

Technical Reports on Medical Equipment Stocks -- Boston Scientific, EnteroMedics, Abbott Laboratories, and Medtronic

This morning, Stock-Callers.com observes the performances of these Medical Appliances and Equipment equities: Boston Scientific Corp. (NYSE: BSX), EnteroMedics Inc. (NASDAQ: ETRM), Abbott Laboratories...

Commercial Patient Data Confirms Success of EnteroMedics' vBloc® Therapy in Combination with vBloc® Achieve Program in Patients Struggling to Lose Weight

EnteroMedics Inc. (NASDAQ:ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced an assessment...

EnteroMedics to Host vBloc® Therapy Commercialization and Corporate Update Conference Call

EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that it will...

EnteroMedics Reports Third Quarter 2016 Financial Results

EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced financial results...

Medical Equipment Stocks Under Review -- EnteroMedics, Amedica, Neovasc, and ResMed

Today, Stock-Callers.com is covering the highly fragmented global Medical Appliances and Equipment space which is expected to reach approximately $302 billion in 2017 with a CAGR of 6.1% during the period...

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Weakening.

See More

Business Summary

EnteroMedics Inc. was established to develop and commercialize a new therapeutic platform for treating a wide range of acute and chronic diseases that are mediated by the vagal nerves. Due to the large unmet need for more effective surgical management of obesity, and following an in-depth analysis of...

See More

Support & Resistance

2nd Resistance Point 7.84
1st Resistance Point 6.73
Last Price 5.62
1st Support Level 4.98
2nd Support Level 4.34

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.